Article Information
- Received March 20, 2013
- Revision received May 4, 2014
- Accepted May 5, 2014
- First published June 4, 2014.
- Version of record published June 4, 2014.
Author Information
- Mohammad Parsanejad1,
- Yi Zhang1,
- Dianbo Qu1,
- Isabella Irrcher1,3,
- Maxime W.C. Rousseaux1,
- Hossein Aleyasin1,
- Fatemeh Kamkar1,
- Steve Callaghan1,
- Ruth S. Slack1,
- Tak W. Mak4,
- Stephen Lee1,
- Daniel Figeys2, and
- David S. Park1,5
- 1Department of Cellular and Molecular Medicine,
- 2Institute of Systems Biology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada,
- 3Department of Ophthalmology, Queen's University, Kingston, Ontario K7L 5G2, Canada,
- 4The Campbell Family Institute for Breast Cancer Research, Toronto, Ontario M5G 2C1, Canada, and
- 5Department of Cogno-Mechatronics Engineering, Pusan National University, Busan 609-735, Korea
Author contributions
Author contributions: M.P., D.Q., M.W.C.R., H.A., R.S.S., T.W.M., S.L., and D.S.P. designed research; M.P., Y.Z., I.I., S.C., and D.F. performed research; D.Q., F.K., S.C., T.W.M., S.L., and D.F. contributed unpublished reagents/analytic tools; M.P. analyzed data; M.P., Y.Z., and D.S.P. wrote the paper.
Disclosures
- Received March 20, 2013.
- Revision received May 4, 2014.
- Accepted May 5, 2014.
This work was supported by grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Parkinson's Society Canada, Parkinson's Research Consortium, Neuroscience Canada/Krembil Foundation, and the Centre for Stroke Recovery. This work also was supported by the World Class University program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology, South Korea (Grant R31-2008-000-20004-0; to D.S.P.). The authors thank Alexander Revello and Dr. Yasmilde Rodriguez Gonzalez, University of Ottawa, Ontario, Canada, for their technical assistance. Authors would also like to thank Dr. Patrizia Rizzu, Medical Genomics VU University Medical Center, The Netherlands, for kindly providing human lymphoblasts.
Daniel Figeys is a Canada Research Chair in Proteomics and Systems Biology.
- Correspondence should be addressed to David S. Park, Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, 451 Smyth Road, Ottawa, Ontario K1H 8M5, Canada. dpark{at}uottawa.ca
